drugset / Trial / NCT02724202

Curcumin in Combination With 5FU for Colon Cancer

NCT02724202

Phase 0 Terminated 15 enrolled Baylor Research Institute
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to test the safety and find the response rate of combining the dietary supplement, curcumin, with the standard of care, FDA-approved chemotherapy drug 5-fluorouracil (5FU, Adracil) and see what effects (good and bad) that the combined treatments have on colon cancer.

Timeline

Start
2018-02-20
Primary completion
2020-01-10
Completion
2020-01-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 500 mg Oral
Background fluorouracil Small molecule